Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Suspended 1Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Leukemia, Myeloid, Acute 77Myelodysplastic Syndromes 20Leukemia, Myelomonocytic, Chronic 11Myeloproliferative Disorders 6Hematologic Neoplasms 5Anemia, Refractory, with Excess of Blasts 4Recurrence 3Neoplasms 3Myelodysplastic-Myeloproliferative Diseases 3Leukemia 3Hematologic Diseases 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Immunoblastic Lymphadenopathy 2Hodgkin Disease 2GATA2 Deficiency 2Sarcoma, Myeloid 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pathologic Complete Response 1Neurofibromatosis 1 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 12Vincristine 9Etoposide 8venetoclax 6Methotrexate 6Doxorubicin 6Dexamethasone 6Cytarabine 6Prednisone 5Calcium Dobesilate 5prednylidene 4pegaspargase 4merphos 4dexamethasone acetate 4dexamethasone 21-phosphate 4deltacortene 4calaspargase pegol 4auricularum 4Specimen Handling 4Granulocyte Colony-Stimulating Factor 4fludarabine phosphate 3daratumumab 3Thioguanine 3Rituximab 3Peripheral Blood Stem Cell Transplantation 3Mercaptopurine 3Magnetic Resonance Spectroscopy 3Leucovorin 3Hydrocortisone 3Filgrastim 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Azacitidine × 90 days × Clear all
NCT07388563 2026-05-08

Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1 Suspended
20 enrolled
LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05376111 2026-03-19

Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients

The First Affiliated Hospital of Soochow University

Phase 2 Recruiting
28 enrolled
LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡